Loading clinical trials...
Loading clinical trials...
Development and Validation of a Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, ultimately leading to ESRD. Although some ESRD prediction models have been derived in the past years, none of these models are dynamic: they do not integrate the repeated measurements recorded throughout individuals' follow-up. As highlighted in several studies, kidney function repeated measurements (i.e., trajectories) are highly associated with graft survival after kidney transplantation. The investigators made the hypothesis that these trajectories may bring relevant information in the context of graft survival risk prediction model. Hence, combining these trajectories with standard graft survival risk factors may enhance prediction performance. This could permit to derive a robust tool that could be updated over time by continuously capturing patient' personal evolution.
850 million individuals suffer from chronic kidney disease (CKD), while diabetes, cancer, and HIV/AIDS affect 422, 42, and 37 million individuals, respectively. End stage renal disease (ESRD) hence places a heavy burden on health systems worldwide. Linked to that, the kidney-disease-associated mortality rate worldwide has risen over the past decade, now causing the death of 5 to 10 million individuals every year. In kidney transplantation, numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, sometimes leading to graft failure. Current approaches for investigating the relationship between these factors and graft failure have been limited by standard statistical approaches and by registries with an overall lack on granular data, including infrequent kidney function measurements for a single patient and convenience clinical samples. Identifying the determinants of graft failure with a dynamic approach may bring an original perspective to the traditional graft survival risk prediction model that are impeded by their reliance on low-granularity datasets, cross-sectional parameters, and limited follow-up.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Department of Medicine, Division of Nephrology, Comprehensive Transplant Center, Cedars Sinai Medical Center
Los Angeles, California, United States
Division of Transplantation, Department of Surgery, Feinberg School of Medicine, Northwestern University
Chicago, Illinois, United States
Department of Surgery, Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic
Rochester, Minnesota, United States
Albert Einstein College of Medicine, Renal Division Montefiore Medical Center, Kidney Transplantation Program
New York, New York, United States
Unidad de Trasplante Renopáncreas, Centro de Educación Médica e Investigaciones Clínicas
Buenos Aires, Argentina
Universidade Federal de São Paulo, Hospital do Rim, Escola Paulista de Medicina
São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Renal Transplantation Service
São Paulo, Brazil
Clinica Alemana de Santiago
Santiago, Chile
Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School od Medicine University of Zagreb
Zagreb, Croatia
Start Date
January 1, 2004
Primary Completion Date
December 31, 2019
Completion Date
June 30, 2020
Last Updated
September 16, 2020
14,000
ESTIMATED participants
No intervention
OTHER
Lead Sponsor
Paris Translational Research Center for Organ Transplantation
NCT05525507
NCT05788276
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions